Link Start Got Investment From Pharmaron To Ensure Future Cooperation

On June 18, 2019, Pharmaon just announced the completion of its investment for Link Start. This investment will make sure Link Start to become a partner with Pharmaron's clinical development team, and both companies will leverage their respective technologies, resources and markets to provide superior clinical services to their clients. This cooperation will also accelerate the development of drugs for Pharmaron.

"Link Start has always been committed to providing partners with high-quality clinical SMO services, and my team and I will have the confidence to accelerate the clinical development of new drugs to build the Chinese SMO reputation around the world," the founder and CEO of Link Start Mr. Yang Liu said.

Pharmaron is a premier R&D service company supporting the life science industry. Founded in 2004, Pharmaron has established diverse drug R&D service capabilities.